Lv3
232 积分 2023-12-12 加入
Human OX40L–CAR-Tregs target activated antigen-presenting cells and control T cell alloreactivity
27天前
已完结
Defining immune reset: achieving sustained remission in autoimmune diseases
1个月前
已完结
Inhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases
2个月前
已完结
Triple knockdown of CD11a , CD49d , and PSGL1 in T cells reduces CAR-T cell toxicity but preserves activity against solid tumors in mice
2个月前
已完结
Engineering synthetic suppressor T cells that execute locally targeted immunoprotective programs
3个月前
已完结
The CD27–CD70 pathway and pathogenesis of autoimmune disease
4个月前
已完结
CD70: An emerging target in cancer immunotherapy
4个月前
已完结
Preclinical Results of an Allogeneic, Universal CD19/CD7-Targeting CAR-T Cell Therapy (GC502) for B Cell Malignancies
4个月前
已完结
Preclinical Results of an Allogeneic, Universal CD19/CD7-Targeting CAR-T Cell Therapy (GC502) for B Cell Malignancies
4个月前
已关闭
Neurological manifestation of immune system dysregulation resulting from CTLA-4 receptor mutation: a case report
4个月前
已完结
皖公网安备34019202002308
